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实验室成立于2007年7月, 于2008年底获批组建厦门市代谢性疾病重点实验
室。主要针对糖尿病、肥胖症、生殖系统疾病、乳腺癌等重大疾病, 从细
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摘要      AGR2(anterior gradient-2)是一种分泌蛋白, 广泛存在于前列腺、乳腺、肺和胰腺等腺
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Abstract        AGR2 is a secreted protein and widely found in the prostate, breast, lung and pancreatic gland 
tissue. It has excessive expression in the tumor tissue of these glands and regulates tumor cell survival, growth and 
metastasis. Clinical expression of AGR2 in breast cancer, prostate cancer and pancreatic cancer is relative to the 
progress of tumor development. Thus, AGR2 is considered to be a promising biomarker for early diagnosis and 
prognosis. In this paper, we reviewed the current research status of AGR2, especially tumor related functions, clini-
cal investigation and mechanisms. 







技 术(suppression subtractive hybridization, SSH)从 乳
腺癌细胞系MCF7的cDNA文库中筛选出非洲爪蟾













1   AGR2蛋白结构和功能形式
人类AGR2基因定位于染色体7p21.3, 有两个转
录产物, 全长分别是0.9 Kb和1.7 Kb, 链短的含量更
丰富, 链长的含量则非常低, 以前分别称之为hAG-2








































































































3   AGR2与癌症























































































































































































AGR2 mRNA在循环肿瘤细胞(circulating tumor cells, 
CTC)中表达升高, 也可以作为诊断的标志物[46]。
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